D.I. SA
D.I. reported total assets of €3.69m at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Apr 2026).
The score of D.I. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +14 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
D.I.'s annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 07 Apr 2026
- Year ended 30 Sep 2024filed on 28 Apr 2025
- Year ended 30 Sep 2023filed on 29 Apr 2024
- Year ended 30 Sep 2022filed on 08 May 2023
- Year ended 30 Sep 2021filed on 02 May 2022
D.I.'s financial analysis
- Solvency99.1%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of D.I.
D.I.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0431.579.328
- VAT number
- BE0431579328
- Peppol
- Registered · 0208:0431579328 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Jul 1987
- Registered office
- 8570 Anzegem
- Latest accounts
- 2025 · filed on 07 Apr 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
D.I. (SA) has been based in Anzegem since 1987, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 283,532 € and equity of €3.66m; its revenue is not published. Its solvency stands at 99.1%, above the median of its sector (45.8%).
Companies similar to D.I.
Companies in the same business, of comparable size and area, outside its group.
- WM Supplies (B) Wholesale of pharmaceutical and medical goods Kuurne · balance sheet €3.17m
- PRO Scan Manufacture of medical and dental instruments and supplies Zonhoven · balance sheet €2.83m
- Phytos Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 2,672 €
- Medim Wholesale of pharmaceutical and medical goods Kruisem · balance sheet €1.89m
- Intermedi Wholesale of pharmaceutical and medical goods Ghent · balance sheet €1.16m
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- Mobio Wholesale of pharmaceutical and medical goods Lokeren · balance sheet €5.25m
- Hospiplan Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €5.29m
Frequently asked questions about D.I.
What is the revenue of D.I.?
D.I. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of D.I.?
In Belgium, the VAT number is the company number prefixed with BE: BE0431579328 for D.I., if the company is VAT-registered. Its company number (CBE) is 0431.579.328.
Where is the registered office of D.I.?
According to the CBE register, the registered office of D.I. is in 8570 Anzegem.
What is the equity of D.I.?
At the close of the 2025 financial year, the equity of D.I. amounts to 3,658,999 €, a solvency of 99.1% of total assets.
Who manages D.I.?
The register lists 4 active mandates at D.I.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of D.I.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →